Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00153803
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2005-09-07
Brief Title:
Erlotinib or Placebo Following Chemoradiotherapy ChemoRT in Stage III Non-Small Cell Lung Cancer NSCLC
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Organization Data
Organization:
Dartmouth-Hitchcock Medical Center
Class:
OTHER
Study ID:
D-0410
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| Sanofi | INDUSTRY |